1-2 of 2
Elisa Lucchini
Close
Sort by
Journal Articles

Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study

Clinical Trials & Observations
Marco Herling, Claire Dearden, Francesco Zaja, Dima El-Sharkawi, Wei Ding, Mar Bellido, Amit Khot, Lidwine Tick, Eric Jacobsen, Toby A. Eyre, Damien Roos-Weil, Tapan Kadia, Elisa Lucchini, Natali Pflug, Matthew S. Davids, German Pena, Nabanita Mukherjee, Mohamed Badawi, Tamas Vizkelety, Philipp B. Staber
Journal: Blood Advances
Blood Adv (2024) 8 (4): 842–845.
https://doi.org/10.1182/bloodadvances.2023012248
Published: 2024
Includes: Supplemental data
Journal Articles

Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial

Clinical Trials & Observations
Simone Ferrero, Daniele Grimaldi, Elena Arrigoni, Mariapia Pironti, Gian Maria Zaccaria, Beatrice Alessandria, Elisa Genuardi, Gabriele De Luca, Marco Ghislieri, Rita Tavarozzi, Alice Di Rocco, Alessandro Re, Vittorio Stefoni, Federica Cavallo, Carola Boccomini, Monica Balzarotti, Vittorio Zilioli, Filipa Moita, Luca Arcaini, Elisa Lucchini, Filippo Ballerini, Andrés J. M. Ferreri, Benedetta Puccini, Giuseppe A. Palumbo, Sara Galimberti, Sergio Cortelazzo, Antonello Di Paolo, Marco Ladetto
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3764–3774.
https://doi.org/10.1182/bloodadvances.2022009504
Published: 2023
Includes: Supplemental data